Tumours from MSH2 mutation carriers show loss of MSH2 expression but many tumours from MLH1 mutation carriers exhibit weak positive MLH1 staining

Microsatellite analysis (MSA) in tumour tissue is useful for pre‐selection of hereditary non‐polyposis colorectal cancer (HNPCC) patients for mutation screening, but is time‐consuming and cost‐intensive. Immunohistochemistry (IHC) for expression of MLH1 and MSH2 proteins is simple, fast, and indicates the affected gene. IHC has therefore been proposed as an alternative pre‐screening method. However, some authors report a lower sensitivity of IHC compared with MSA. The present study reports IHC results for MSH2 and MLH1 performed in 82 tumours with high microsatellite instability (MSI‐H) from 81 carriers of pathogenic mutations in MSH2 or MLH1. One hundred per cent (38/38) of the tumours from MSH2 mutation carriers showed loss of MSH2 staining; in all cases, the affected MSH2 gene was predicted correctly by IHC. Complete loss of MLH1 expression was observed in 66% (29/44) of MLH1 mutation carriers. Weak positive MLH1 staining was observed in 14 (32%) cases and, in one case, normal MLH1 staining was seen. The pathologist was aware of the weak staining pattern as an indicator of an MLH1 mutation; 98% of the MLH1 mutations were predicted correctly. To evaluate whether weak positive MLH1 staining is observed more often with in‐frame or missense mutations, IHC data from 23 MSI‐H tumours from carriers of unspecified variants were added and mutations were grouped into truncating mutations, large non‐truncating deletions, and small non‐truncating mutations. Weak MLH1 staining was observed in all three categories and it is postulated that other factors, such as mutation of the second allele, also influence protein expression. In conclusion, IHC can be regarded as a very useful method for selecting HNPCC patients for mutation analysis, as long as it is interpreted by an experienced pathologist. The high specificity of IHC in terms of indicating the affected gene is useful for evaluating unspecified variants. However, the staining pattern does not predict whether the underlying germ‐line mutation is truncating or not. Copyright © 2005 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd.

[1]  W. Gerald,et al.  Value of Immunohistochemical Detection of DNA Mismatch Repair Proteins in Predicting Germline Mutation in Hereditary Colorectal Neoplasms , 2005, The American journal of surgical pathology.

[2]  L. Forétova,et al.  Immunohistochemical detection of the hMLH1 and hMSH2 proteins in hereditary non-polyposis colon cancer and sporadic colon cancer. , 2004, Neoplasma.

[3]  D. Aust,et al.  Identification of six novel MSH2 and MLH1 germline mutations in HNPCC , 2003, Human mutation.

[4]  H. Morreau,et al.  Conventional and tissue microarray immunohistochemical expression analysis of mismatch repair in hereditary colorectal tumors. , 2003, The American journal of pathology.

[5]  Hong Zhang,et al.  Combined deficiency of hMLH1, hMSH2, hMSH3 and hMSH6 is an independent prognostic factor in colorectal cancer. , 2003, International journal of oncology.

[6]  T. Ørntoft,et al.  Antibody‐based screening for hereditary nonpolyposis colorectal carcinoma compared with microsatellite analysis and sequencing , 2002, Cancer.

[7]  J. Terdiman,et al.  Comparison of selection strategies for genetic testing of patients with hereditary nonpolyposis colorectal carcinoma , 2002, Cancer.

[8]  R. Hofstra,et al.  Description and functional analysis of a novel in frame mutation linked to hereditary non-polyposis colorectal cancer , 2002, Journal of medical genetics.

[9]  R. Scott,et al.  Impact of microsatellite testing and mismatch repair protein expression on the clinical interpretation of genetic testing in hereditary non-polyposis colorectal cancer , 2002, Journal of Cancer Research and Clinical Oncology.

[10]  M. Loda,et al.  Evaluation of Microsatellite Instability and Updated Version Cited Articles Citing Articles E-mail Alerts Evaluation of Microsatellite Instability and Immunohistochemistry for the Prediction of Germ-line Msh2 and Mlh1 Mutations in Hereditary Nonpolyposis Colon Cancer Families , 2022 .

[11]  G. Suthers,et al.  Correlation of mismatch repair genes immunohistochemistry and microsatellite instability status in HNPCC‐associated tumours , 2002, Pathology.

[12]  A. de la Chapelle.  Microsatellite instability phenotype of tumors: genotyping or immunohistochemistry? The jury is still out. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[13]  A. Lindblom,et al.  Microsatellite Instability and hMLH1 and hMSH2 Expression Analysis in Familial and Sporadic Colorectal Cancer , 2001, Laboratory Investigation.

[14]  V. Weinberg,et al.  Efficient detection of hereditary nonpolyposis colorectal cancer gene carriers by screening for tumor microsatellite instability before germline genetic testing. , 2001, Gastroenterology.

[15]  M. Cravo,et al.  Immunohistochemical detection of mismatch repair gene proteins as a useful tool for the identification of colorectal carcinoma with the mutator phenotype , 2000, The Journal of pathology.

[16]  L. Aaltonen,et al.  Controlled 15-year trial on screening for colorectal cancer in families with hereditary nonpolyposis colorectal cancer. , 2000, Gastroenterology.

[17]  T. Liu,et al.  Microsatellite instability as a predictor of a mutation in a DNA mismatch repair gene in familial colorectal cancer , 2000, Genes, chromosomes & cancer.

[18]  J. Kładny,et al.  Value of pedigree/clinical data, immunohistochemistry and microsatellite instability analyses in reducing the cost of determining hMLH1 and hMSH2 gene mutations in patients with colorectal cancer. , 2000, European journal of cancer.

[19]  A. de la Chapelle,et al.  Genetic susceptibility to non-polyposis colorectal cancer , 1999, Journal of medical genetics.

[20]  A. Millar,et al.  Immunohistochemistry for hMLH1 and hMSH2: a practical test for DNA mismatch repair-deficient tumors. , 1999, The American journal of surgical pathology.

[21]  H T Lynch,et al.  New clinical criteria for hereditary nonpolyposis colorectal cancer (HNPCC, Lynch syndrome) proposed by the International Collaborative group on HNPCC. , 1999, Gastroenterology.

[22]  T. Sauerbruch,et al.  Microsatellite instability—a useful diagnostic tool to select patients at high risk for hereditary non-polyposis colorectal cancer: a study in different groups of patients with colorectal cancer , 1999, Gut.

[23]  L. Aaltonen,et al.  Cancer risk in mutation carriers of DNA‐mismatch‐repair genes , 1999, International journal of cancer.

[24]  H. Lynch,et al.  GENETIC SUSCEPTIBILITY TO NONPOLYPOSIS COLORECTAL CANCER , 1999 .

[25]  S Srivastava,et al.  A National Cancer Institute Workshop on Microsatellite Instability for cancer detection and familial predisposition: development of international criteria for the determination of microsatellite instability in colorectal cancer. , 1998, Cancer research.

[26]  S. Thibodeau,et al.  Search for chromosome instability in lymphocytes with germ-line mutations in DNA mismatch repair genes. , 1998, Cancer genetics and cytogenetics.

[27]  C. Boland,et al.  A National Cancer Institute Workshop on Hereditary Nonpolyposis Colorectal Cancer Syndrome: meeting highlights and Bethesda guidelines. , 1997, Journal of the National Cancer Institute.

[28]  S. Thibodeau,et al.  Altered expression of hMSH2 and hMLH1 in tumors with microsatellite instability and genetic alterations in mismatch repair genes. , 1996, Cancer research.

[29]  M. Kohonen-Corish,et al.  RNA-based mutation screening in hereditary nonpolyposis colorectal cancer. , 1996, American journal of human genetics.

[30]  B. Ponder,et al.  Mutation screening of MSH2 and MLH1 mRNA in hereditary non-polyposis colon cancer syndrome. , 1996, Journal of medical genetics.

[31]  B. Vogelstein,et al.  Expression of the human mismatch repair gene hMSH2 in normal and neoplastic tissues. , 1996, Cancer research.

[32]  S N Thibodeau,et al.  Microsatellite instability in cancer of the proximal colon. , 1993, Science.

[33]  J. Mecklin,et al.  The International Collaborative Group on Hereditary Non-Polyposis Colorectal Cancer (ICG-HNPCC) , 1991, Diseases of the colon and rectum.